Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 July 2006, Vol. 108, No. 1, pp. 116-122.
Prepublished online as a Blood First Edition Paper on December 8, 2005; DOI 10.1182/blood-2005-06-2245.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
2005-06-2245v1
108/1/116    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bijl, J.
Right arrow Articles by Sauvageau, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bijl, J.
Right arrow Articles by Sauvageau, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 6, 2005
Accepted October 15, 2005

Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells

Janet Bijl, Alexander Thompson, Ramiro Ramirez-Solis, Jana Krosl, David G Grier, H J Lawrence, and Guy Sauvageau*

Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer (IRIC), Montreal, Quebec, Canada
Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer (IRIC), Montreal, Quebec, Canada; Departments of Haematology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
Child Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
Department of Medicine, VA Medical Center and University of California, University of California, San Francisco, California, USA
Laboratory of Molecular Genetics of Stem Cells, Institute for Research in Immunology and Cancer (IRIC), Montreal, Quebec, Canada; Leukemia Cell Bank of Quebec and Division of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; Department of Medicine, Universite de Montreal, Montreal, Quebec, Canada

* Corresponding author; email: guy.sauvageau{at}umontreal.ca.

Overexpression of Hoxb4 in bone marrow cells promotes expansion of hematopoietic stem cell populations in vivo and in vitro, indicating that this homeoprotein can activate the genetic program which determines self-renewal. However, this function cannot be solely attributed to Hoxb4, since Hoxb4-/- mice are viable and have apparently normal HSC pools. Q-PCR analysis showed that Hoxb4-/- c-Kit+ fetal liver cells expressed moderately higher levels of several Hoxb cluster genes than control cells, raising the possibility that normal HSC activity in Hoxb4-/- mice is due to a compensatory upregulation of other Hoxb genes. In this study, we investigated the competitive repopulation potential of HSCs lacking Hoxb4 alone, or in conjunction with eight other Hoxb genes. Our results show that Hoxb4-/- and Hoxb1-b9-/- fetal liver cells retain full competitive repopulation potential, and the ability to regenerate all myeloid and lymphoid lineages examined. Quantitative Hox gene expression profiling in purified c-Kit+ Hoxb1-b9-/- fetal liver cells revealed an interaction between the Hoxa, b and c clusters with variation in expression levels of Hoxa4, -a11 and -c4. Together, these studies show a complex network of genetic interactions between several Hox genes in primitive hematopoietic cells and demonstrate that HSCs lacking up to 30% of the active Hox genes remain fully competent.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y.-L. Hu, E. Passegue, S. Fong, C. Largman, and H. J. Lawrence
Evidence that the Pim1 kinase gene is a direct target of HOXA9
Blood, June 1, 2007; 109(11): 4732 - 4738.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020